Baidu
map

PLOS ONE:合并抑郁增加糖尿病患者死亡风险

2013-03-19 刘沛 编译 医学论坛网

  一项新的研究表明,合并抑郁可使糖尿病患者死亡风险增高1.5倍。研究由荷兰马斯特里赫特大学医学中心van Dooren等人进行,于2013年3月5日在线发表于《PLoS One》杂志[PLoS One. 2013;8(3):e57058]。   研究者在PUBMED和PSYCINFO数据库中检索截至2012年8月16日的主题为糖尿病患者抑郁相关死亡风险的

  一项新的研究表明,合并抑郁可使糖尿病患者死亡风险增高1.5倍。研究由荷兰马斯特里赫特大学医学中心van Dooren等人进行,于2013年3月5日在线发表于《PLoS One》杂志[PLoS One. 2013;8(3):e57058]。

  研究者在PUBMED和PSYCINFO数据库中检索截至2012年8月16日的主题为糖尿病患者抑郁相关死亡风险的文章,通过系统性回顾文献和对纵向研究的荟萃分析探讨糖尿病患者心血管死亡率与抑郁及全因死亡之间的相关性,应用随机效应模型计算危险比。

  最终16项评估了全因死亡率的研究符合纳入标准,其中5项研究评估了心血管死亡率。研究者在校正人口、微血管及大血管并发症等因素后发现,抑郁与糖尿病患者全因死亡风险增加相关(HR=1.46,95%可信区间1.29-1.66),与心血管死亡率相关(HR=1.39,95%可信区间1.11-1.73)。

  全因死亡在不同研究之间的异质性较高,而心血管死亡的异质性相对较低,I平方分别为78.6%和39.6%。亚组分析显示,抑郁和死亡率的相关性在排除三篇统计比值比的文章后无明显变化,而异质性明显降低(HR=1.49,95%可信区间=1.39-1.61,I平方=15.1%)。

  研究者指出,在进一步的研究中应关注抑郁相关的心血管与非心血管原因所致死亡,及其潜在的行为学与生理学机制。


Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis

OBJECTIVE:

To examine the association between depression and all-cause and cardiovascular mortality in people with diabetes by systematically reviewing the literature and carrying out a meta-analysis of relevant longitudinal studies.

RESEARCH DESIGN AND METHODS:

PUBMED and PSYCINFO were searched for articles assessing mortality risk associated with depression in diabetes up until August 16, 2012. The pooled hazard ratios were calculated using random-effects models.

RESULTS:

Sixteen studies met the inclusion criteria, which were pooled in an overall all-cause mortality estimate, and five in a cardiovascular mortality estimate. After adjustment for demographic variables and micro- and macrovascular complications, depression was associated with an increased risk of all-cause mortality (HR = 1.46, 95% CI = 1.29-1.66), and cardiovascular mortality (HR = 1.39, 95% CI = 1.11-1.73). Heterogeneity across studies was high for all-cause mortality and relatively low for cardiovascular mortality, with an I-squared of respectively 78.6% and 39.6%. Subgroup analyses showed that the association between depression and mortality not significantly change when excluding three articles presenting odds ratios, yet this decreased heterogeneity substantially (HR = 1.49, 95% CI = 1.39-1.61, I-squared = 15.1%). A comparison between type 1 and type 2 diabetes could not be undertaken, as only one study reported on type 1 diabetes specifically.

CONCLUSIONS:

Depression is associated with an almost 1.5-fold increased risk of mortality in people with diabetes. Research should focus on both cardiovascular and non-cardiovascular causes of death associated with depression, and determine the underlying behavioral and physiological mechanisms that may explain this association.



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1789505, encodeId=26201e89505d3, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed Jul 31 10:20:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983406, encodeId=ac2e19834066c, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Jun 07 04:20:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255435, encodeId=e2e01255435b5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473690, encodeId=241c14e369060, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1789505, encodeId=26201e89505d3, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed Jul 31 10:20:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983406, encodeId=ac2e19834066c, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Jun 07 04:20:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255435, encodeId=e2e01255435b5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473690, encodeId=241c14e369060, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1789505, encodeId=26201e89505d3, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed Jul 31 10:20:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983406, encodeId=ac2e19834066c, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Jun 07 04:20:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255435, encodeId=e2e01255435b5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473690, encodeId=241c14e369060, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1789505, encodeId=26201e89505d3, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed Jul 31 10:20:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983406, encodeId=ac2e19834066c, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Jun 07 04:20:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255435, encodeId=e2e01255435b5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473690, encodeId=241c14e369060, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Mar 21 01:20:00 CST 2013, time=2013-03-21, status=1, ipAttribution=)]

相关资讯

葛兰素史克提交Albiglutide上市申请

  葛兰素史克公司于2013年3月7日表示,已向欧洲药监部门提交了旗下每周注射一次的糖尿病新药Albiglutide的上市申请,力求能在竞争激烈的糖尿病药物市场占有一席之地。   Albiglutid属人胰高糖素样肽-1(GLP-1)类药物,用于治疗2型糖尿病。葛兰素史克公司发言人表示, Albiglutid目前在全球范围内还没有获得上市批准。   分析人士指该产品可能会成为GLP-

NEJM:人工胰腺降低院外患者夜间低血糖

人工胰腺降低院外患者夜间低血糖    以色列国家儿童糖尿病研究中心Phillip等人进行的一项研究发现,与传感器增强型胰岛素泵治疗相比,人工胰腺体系治疗院外糖尿病患者可减少夜间低血糖症,且血糖控制得到改善。该研究结果在线发表于新一期的《新英格兰杂志》[N Engl J Med. 2013 Feb 28;368(9):824-3

DIABETES CARE:糖尿病患者冠脉狭窄风险明显升高

    一项最新研究显示,我国早期糖尿病患者中无心肌缺血症状者,其发生冠脉狭窄的风险明显升高。血糖水平是糖尿病患者发生冠脉狭窄的独立危险因素。研究由上海交通大学医学院附属瑞金医院宁光等人进行,2013年3月5日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究旨在评价无心肌缺血症状的中国成年糖尿病患者或糖尿病前期人群的冠脉狭窄风险。研究者从社

PLOS ONE:强化降糖或使肥胖糖尿病患者获益

  一项覆盖9项随机对照研究、59 197例受试者的Meta分析提示,对于体质指数(BMI)>30 kg/m2的糖尿病患者,与标准降糖方案相比,强化降糖方案可有效降低卒中发生风险。(PLoS One. 2013,8:e54465)   在被纳入的59 197例受试者中,2037例罹患卒中。分析结果显示,在整个受试人群中,与标准降糖方案相比,

Diabetes Care:美国糖尿病患者“三达标率”较高

  美国学者Sarah Stark Casagrande等报告,2007-2010年间有18.8%的美国糖尿病患者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDL-C)水平同时达标,达标率是我国糖尿病患者(5.6%)的3倍以上。研究于2013年2月15日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究者利用1988-2010年美国国

Diabetes Care:空气污染诱发糖尿病患者炎症反应

  《糖尿病护理》杂志日前发表伊朗和印度科学家合作完成的一项新研究[Diabetes Care. 2013 Mar;36(3):625-30]称,空气污染可能诱发2型糖尿病患者全身性炎症反应,增加其发生血管并发症的风险。   血浆C-反应蛋白(CRP)水平与胰岛素抵抗、糖尿病及其并发症呈现相关性,血浆CRP水平下降有助于降低胰岛素抵抗、糖尿病并发症发生风险。伊朗让迪

Baidu
map
Baidu
map
Baidu
map